$217.91 -1.33 (%) Valeant Pharmaceuticals International Inc - NYSE

May. 6, 2015 | 11:14 AM

Partner Headlines

  1. Is The Drug Industry's Wedding Dance Nearly Finished?

    IBD | May. 1, 2015 | 16:08PM EST
  2. Hot No More: Many Top Stocks Hig With Severe Declines

    IBD | Apr. 30, 2015 | 18:22PM EST
  3. Wednesday's After-Hours Movers: Yelp, Glu Mobile And More

    Benzinga | Apr. 29, 2015 | 17:31PM EST
  4. Valeant Beats Q1 Views, Lifts Guidance, Loses CFO

    IBD | Apr. 29, 2015 | 17:13PM EST
  5. Indexes Lower, Near Session Lows As Fed Announcement Nears

    IBD | Apr. 29, 2015 | 13:22PM EST
  6. Valeant Beats Q1 Views, Lifts Guidance, But Loses CFO

    IBD | Apr. 29, 2015 | 10:55AM EST
  7. Weak GDP Data Shakes Up Stocks; Buffalo Wild Folds Its Wings

    IBD | Apr. 29, 2015 | 10:34AM EST
  8. Valeant Posts Upbeat Q1 Results, Lifts Full-Year Forecast

    Benzinga | Apr. 29, 2015 | 07:48AM EST
  9. Twitter's Premature Earnings Release Caps Volatile Session

    IBD | Apr. 28, 2015 | 17:00PM EST
  10. 4 Top-Rated Drugmakers Reporting Earnings This Week

    IBD | Apr. 26, 2015 | 08:02AM EST
  11. Submit Questions for Upcoming Q&A With Value Investor Wally Weitz

    GuruFocus | Apr. 24, 2015 | 14:42PM EST
  12. Autohome, Other Foreign Stock Leaders Seen Posting Big Q1 Growth

    IBD | Apr. 13, 2015 | 17:17PM EST
  13. The Top Guru-Held Canadian Stocks

    GuruFocus | Apr. 11, 2015 | 23:51PM EST
  14. Big Cap 20 Reflecting Market Leadership

    IBD | Mar. 2, 2015 | 18:44PM EST
  15. IBD 50 Performance Ramps Up; Several Setups Emerge

    IBD | Feb. 27, 2015 | 18:45PM EST
  16. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 27, 2015 | 16:27PM EST
  17. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 26, 2015 | 19:47PM EST
  18. Jazz Pharmaceuticals Tops Q4 Earnings And Tests Buy Point

    IBD | Feb. 26, 2015 | 11:51AM EST
  19. Morgan Stanley Reiterates Overweight, Raises Price Target On Valeant Pharmaceuticals On New Proforma Model For SLXP

    Benzinga | Feb. 26, 2015 | 09:22AM EST
  20. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  21. Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price Target

    Benzinga | Feb. 25, 2015 | 11:31AM EST
  22. Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity

    Benzinga | Feb. 24, 2015 | 16:00PM EST
  23. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  24. Firms Bullish On Valeant Following Earnings, Acquisition

    Benzinga | Feb. 24, 2015 | 13:44PM EST
  25. Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals

    GuruFocus | Feb. 24, 2015 | 12:09PM EST
  26. 4 Pictures Every Valeant-Salix Investor Should See

    Benzinga | Feb. 23, 2015 | 18:59PM EST
  27. Taxes Put U.S. Firms On Sale

    IBD | Feb. 23, 2015 | 18:54PM EST
  28. Tax System Gives Edge To Foreign Buys Of U.S. Firms

    IBD | Feb. 23, 2015 | 18:51PM EST
  29. Bristol-Myers goes for the gut

    IBD | Feb. 23, 2015 | 18:33PM EST
  30. Nasdaq Stretches Win Streak To 9 Days

    IBD | Feb. 23, 2015 | 17:03PM EST
  31. Nasdaq Climbs As Apple Stock Hits New High

    IBD | Feb. 23, 2015 | 16:23PM EST
  32. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  33. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  34. JMP Securities Comments On Salix Pharmaceutical's Takeover Valuation

    Benzinga | Feb. 23, 2015 | 14:41PM EST
  35. Valeant CEO Explains Why The Company Is Acquiring Salix For $10.1 Billion Cash Instead Of An Equity Offering

    Benzinga | Feb. 23, 2015 | 14:27PM EST
  36. Stocks Quietly Lower; Domino's, Medivation Break Out

    IBD | Feb. 23, 2015 | 13:18PM EST
  37. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  38. Stocks Edge Lower, Oil Falls, But Managed-Care Firms Shine

    IBD | Feb. 23, 2015 | 11:47AM EST
  39. Update: Marathon Pharma Sold Hospital Products To Valeant

    Benzinga | Feb. 23, 2015 | 10:42AM EST
  40. Cramer: Valeant's Stock Doesn't Stop Here, It Goes Higher

    Benzinga | Feb. 23, 2015 | 10:29AM EST
  41. Stocks Open Quietly in The Red; Nationstar, Valeant, Tower Rise

    IBD | Feb. 23, 2015 | 10:24AM EST
  42. Benzinga's Volume Movers

    Benzinga | Feb. 23, 2015 | 10:22AM EST
  43. Stocks Hitting 52-Week Highs

    Benzinga | Feb. 23, 2015 | 10:12AM EST
  44. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST
  45. Stock Futures Dip, But Not Much; Valeant, Polypore, AerCap Surge

    IBD | Feb. 23, 2015 | 09:07AM EST
  46. Monday's #PreMarket Movers: Spectrum Pharmaceuticals, Cyberark Software Trending Down

    Benzinga | Feb. 23, 2015 | 08:57AM EST
  47. US Stock Futures Slip Ahead Of Economic Data

    Benzinga | Feb. 23, 2015 | 07:12AM EST
  48. Valeant Pharmaceuticals Will Buy Salix For $14.5 Billion

    IBD | Feb. 22, 2015 | 17:46PM EST
  49. Benzinga's Weekend M&A Chatter

    Benzinga | Feb. 22, 2015 | 17:17PM EST
  50. A Look At 5 IBD 50 Stocks With Upcoming Earnings

    IBD | Feb. 21, 2015 | 08:02AM EST
Trading Center